PMV Pharmaceuticals (PMVP) vs Vivani Medical (VANI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
PMV Pharmaceuticals (PMVP) has outperformed Vivani Medical (VANI) over the past year, gaining 4.9% versus a loss of 10.9%. Over five years, VANI leads with a -86.0% price change compared with -93.8% for PMVP. PMV Pharmaceuticals is the larger company by market cap ($117.6 million vs $111.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PMVP | VANI |
|---|---|---|
| Share price | $1.56 | $1.23 |
| Market cap | $117.63M | $110.95M |
| 1-day change | +4.54% | 0.00% |
| YTD return | +19.20% | 0.00% |
| 1-year return | +4.93% | -10.87% |
| 5-year return | -93.78% | -85.96% |
| EPS (TTM) | $-1.42 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.91 | $1.92 |
| 52-week low | $1.02 | $0.923 |
| Distance from 52-week high | -18.45% | -35.94% |
| Analyst consensus | none | none |
| Avg. price target upside | +169.63% | +211.38% |
| Average volume | 661.39K | 228.48K |
| Shares outstanding | 75.51M | 90.20M |
| Employees | 54 | 42 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PMVP has outperformed VANI by 15.8 percentage points over the past year.
About PMV Pharmaceuticals
PMVP stock →PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 54 employees
About Vivani Medical
VANI stock →Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 42 employees
PMVP vs VANI FAQ
Which is bigger, PMV Pharmaceuticals or Vivani Medical?
PMV Pharmaceuticals (PMVP) is larger, with a market capitalization of $117.63M compared with $110.95M for Vivani Medical (VANI).
Which stock has performed better over the past year, PMVP or VANI?
PMVP returned +4.93% over the past 12 months, compared with -10.87% for VANI (price return, excluding dividends). Past performance does not predict future results.
Are PMV Pharmaceuticals and Vivani Medical in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for PMV Pharmaceuticals and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Vivani Medical.